カテゴリ： MarketLine, オランダ, 企業調査

Vesteda Group：企業の戦略・SWOT・財務情報

◆英語タイトル：Vesteda Group - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C3789
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：28
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：オランダ
◆産業分野：建設・建築
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Vesteda Group – Strategy, SWOT and Corporate Finance Report
Summary

Vesteda Group – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Vesteda Group (Vesteda) is a real estate investment and development company that develops, manages and sells homes, and residential and corporate housing properties. It also offers real estate funds for housing and home development including residential units and other properties in residential projects. The company also provides commercial, administrative and technical property management services such as rentals and others related project sale activities. Vesteda provides services to its tenants such as home maintenance, change home, faults and repairs, service costs and caretaker. The company caters to mid-income households, senior citizens, single-person households and dual-income households. Vesteda is headquartered in Amsterdam, North Holland, the Netherlands.

Scope

- Detailed information on Vesteda Group required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vesteda Group in the form of a SWOT analysis
- An in-depth view of the business model of Vesteda Group including a breakdown and examination of key business segments
- Intelligence on Vesteda Group’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vesteda Group, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Vesteda Group and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vesteda Group as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Vesteda Group’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Vesteda Group: Company Overview 6
Vesteda Group: Overview and Key Facts 6
Vesteda Group: Overview 6
Vesteda Group: Key Facts 6
Vesteda Group: Key Employees 7
Vesteda Group: Key Employee Biographies 8
Vesteda Group: Major Products and Services 9
Vesteda Group: Company History 10
Vesteda Group: Management Statement 12
Vesteda Group: Key Competitors 15
Vesteda Group: Company Analysis 16
Vesteda Group: Business Description 16
Vesteda Group: SWOT Analysis 17
Vesteda Group: SWOT Overview 17
Vesteda Group: Strengths 17
Vesteda Group: Weaknesses 17
Vesteda Group: Opportunities 18
Vesteda Group: Threats 18
Vesteda Group: Recent Developments 20
Vesteda Group: News and Events Summary 20
Vesteda Group: Business Expansion 22
Vesteda Group: Contracts 22
Vesteda Group: Corporate Governance 24
Vesteda Group: Regulatory and Legal Events 25
Vesteda Group: Strategy and Operations 25
Appendix 26
Contact Us 26
Methodology 26
About MarketLine 27

List of Tables
Table 1: Vesteda Group: Key Facts
Table 2: Vesteda Group: Key Employees
Table 3: Vesteda Group: Key Competitors
Table 4: Vesteda Group: News and Events Summary
Table 5: Vesteda Group: Business Expansion
Table 6: Vesteda Group: Contracts
Table 7: Vesteda Group: Corporate Governance
Table 8: Vesteda Group: Regulatory and Legal Events
Table 9: Vesteda Group: Strategy and Operations



★海外企業調査レポート[Vesteda Group：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Boston Children’s Hospital：企業の戦略的SWOT分析
    Boston Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • ContraVir Pharmaceuticals Inc (CTRV)：製薬・医療：M&Aディール及び事業提携情報
    Summary ContraVir Pharmaceuticals Inc (ContraVir) is a biopharmaceutical company that offers development and commercialization of targeted antiviral therapies. The company provides pipeline product such as TXL, potent prodrug of antiviral tenofovir and CRV431 cyclophilin inhibitor that increases its …
  • Yangarra Resources Ltd (YGR)：石油・ガス：M&Aディール及び事業提携情報
    Summary Yangarra Resources Ltd (Yangarra) is an oil and gas company that explores, develops and produces oil and natural gas resources. The company owns and operates oil and gas properties in Medicine Hat, Central Alberta, and Jaslan. It has infrastructure and land holdings. Central Alberta producti …
  • Icici Bank Ltd
    Icici Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Icici Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Mission Therapeutics Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Mission Therapeutics Ltd (Mission) is a provider of deubiquitylating enzyme drug discovery and development programs. The company develops USP30, USP10 and UHCL1 for patients with mitochondria diseases, neurodegeneration, inflammation and others. the company uses its proprietaryDUB platform t …
  • Iroko Pharmaceuticals LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary Iroko Pharmaceuticals LLC (Iroko) is a pharmaceutical company that develops treatment options for responsible pain management. The company’s products comprise low dose Nonsteroidal anti-inflammatory drugs such as meloxicam, indomethacin, and diclofenac that are in various stages of nonclinic …
  • Korea Line Corp (005880)：企業の財務・戦略的SWOT分析
    Summary Korea Line Corp (KLC) is a shipping company that offers tramper carrier services and dedicated carrier services. The company transports liquid natural gas through vessels and provides tramper carrier service related to dry bulk products. It also transports iron ore, grain, coal, liquid oil, …
  • Sika AG (SIKA)：企業の財務・戦略的SWOT分析
    Sika AG (SIKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Avingtrans Plc (AVG)：企業の財務・戦略的SWOT分析
    Avingtrans Plc (AVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Samsung Biologics Co Ltd (207940)：製薬・医療：M&Aディール及び事業提携情報
    Summary Samsung Biologics Co Ltd (Samsung Biologics) is a biologics development and manufacturing company. The company’s business activities include process development, contract manufacturing, aseptic fill and finish and project management. Samsung Biologics cell culture development process include …
  • Albemarle Corporation：企業の戦略・SWOT・財務分析
    Albemarle Corporation - Strategy, SWOT and Corporate Finance Report Summary Albemarle Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Miragen Therapeutics Inc (MGEN)：製薬・医療：M&Aディール及び事業提携情報
    Summary Miragen Therapeutics, Inc. (Miragen) is a clinical stage biopharmaceutical company. It discovers and develops RNA-targeted therapeutics with a focus on microRNAs and their role in diseases. The company is developing its pipeline products for the treatment of Cutaneous T-Cell Lymphoma (CTCL), …
  • Highland Gold Mining Limited
    Highland Gold Mining Limited - Strategy, SWOT and Corporate Finance Report Summary Highland Gold Mining Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • John Keells Holdings PLC (JKH.N0000)：企業の財務・戦略的SWOT分析
    Summary John Keells Holdings PLC (John Keells) is a business and consumer services company that provides hotel management services. The company offers services such as airline and aviation services, cinnamon hotels and resorts services, holiday and tour consulting services, port and marine fuel serv …
  • Noel Gifts International Ltd. (543)：企業の財務・戦略的SWOT分析
    Noel Gifts International Ltd. (543) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Ascential plc：企業の戦略・SWOT・財務情報
    Ascential plc - Strategy, SWOT and Corporate Finance Report Summary Ascential plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Nanobiotix SA (NANO)：企業の財務・戦略的SWOT分析
    Summary Nanobiotix SA (Nanobiotix) designs and manufactures nanomedicines for the treatment of cancer. The company is evaluating its lead product candidate NBTXR3 against soft tissue sarcoma, pancreatic, liver, rectal, prostate, head and neck cancers; Non-small cell lung cancer (NSCLC); recurrent he …
  • Purdue Pharma LP-製薬・医療分野：企業M&A・提携分析
    Summary Purdue Pharma LP (Purdue) is a privately held, US-based pharmaceutical company which develops pharmacologic therapies for the treatment and management of pain. The company undertakes the research, development, manufacture and marketing of prescription medicines and over-the-counter (OTC) med …
  • Tokyu Corporation：企業の戦略・SWOT・財務情報
    Tokyu Corporation - Strategy, SWOT and Corporate Finance Report Summary Tokyu Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Marshall of Cambridge (Holdings) Ltd：戦略・SWOT・企業財務分析
    Marshall of Cambridge (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Marshall of Cambridge (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆